Free Trial

Procter & Gamble's (PG) Neutral Rating Reiterated at JPMorgan Chase & Co.

Procter & Gamble logo with Consumer Staples background

Key Points

  • JPMorgan Chase & Co. has reiterated a neutral rating for Procter & Gamble (PG) and lowered its price target from $178.00 to $170.00, indicating a potential upside of 7.04% from current levels.
  • Other analysts have also adjusted their ratings, with UBS lowering its target to $180.00, while Barclays raised it slightly to $161.00.
  • Procter & Gamble's stock has recently shown signs of stability, with a market cap of $372.37 billion and shares trading at approximately $158.82.
  • Interested in Procter & Gamble? Here are five stocks we like better.
  • Limited Time Offer: Unlock powerful research tools, advanced financial data, and expert insights to help you invest with confidence. Save 50% when you upgrade to MarketBeat All Access during the month of July. Claim your discount here.

Procter & Gamble (NYSE:PG - Get Free Report)'s stock had its "neutral" rating reaffirmed by equities research analysts at JPMorgan Chase & Co. in a research note issued on Friday,Benzinga reports. They currently have a $170.00 price objective on the stock, down from their prior price objective of $178.00. JPMorgan Chase & Co.'s price target points to a potential upside of 7.04% from the stock's current price.

A number of other analysts have also commented on PG. UBS Group lowered their target price on shares of Procter & Gamble from $186.00 to $180.00 and set a "buy" rating for the company in a report on Thursday, July 17th. Barclays boosted their price target on shares of Procter & Gamble from $160.00 to $161.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 15th. Bank of America cut their price target on shares of Procter & Gamble from $190.00 to $180.00 and set a "buy" rating on the stock in a research report on Friday, April 25th. Piper Sandler raised their target price on shares of Procter & Gamble from $160.00 to $164.00 and gave the stock a "neutral" rating in a report on Monday, May 5th. Finally, Evercore ISI reaffirmed an "in-line" rating and set a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Nine analysts have rated the stock with a hold rating, ten have issued a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, Procter & Gamble currently has an average rating of "Moderate Buy" and a consensus price target of $176.12.

Get Our Latest Analysis on Procter & Gamble

Procter & Gamble Stock Up 0.3%

Shares of PG opened at $158.82 on Friday. The stock has a market cap of $372.37 billion, a price-to-earnings ratio of 25.21, a P/E/G ratio of 4.51 and a beta of 0.40. The company has a quick ratio of 0.50, a current ratio of 0.71 and a debt-to-equity ratio of 0.47. Procter & Gamble has a 12 month low of $151.90 and a 12 month high of $180.43. The company has a 50-day moving average price of $161.12 and a two-hundred day moving average price of $164.24.

Procter & Gamble (NYSE:PG - Get Free Report) last posted its earnings results on Thursday, April 24th. The company reported $1.54 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.53 by $0.01. The company had revenue of $19.78 billion during the quarter, compared to analysts' expectations of $20.42 billion. Procter & Gamble had a net margin of 18.46% and a return on equity of 32.67%. Procter & Gamble's quarterly revenue was down 2.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.52 earnings per share. Equities analysts predict that Procter & Gamble will post 6.91 EPS for the current fiscal year.

Insider Activity

In other news, CEO Jennifer L. Davis sold 1,000 shares of the business's stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $161.38, for a total transaction of $161,380.00. Following the completion of the transaction, the chief executive officer directly owned 51,965 shares of the company's stock, valued at $8,386,111.70. The trade was a 1.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Moses Victor Javier Aguilar sold 10,520 shares of the company's stock in a transaction that occurred on Monday, May 5th. The stock was sold at an average price of $158.67, for a total transaction of $1,669,208.40. Following the completion of the transaction, the insider owned 25,182 shares of the company's stock, valued at approximately $3,995,627.94. The trade was a 29.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.18% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Procter & Gamble

Hedge funds and other institutional investors have recently made changes to their positions in the company. Kingstone Capital Partners Texas LLC increased its stake in Procter & Gamble by 655,209.0% in the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock worth $11,832,680,000 after buying an additional 76,017,350 shares during the period. Nuveen LLC bought a new position in Procter & Gamble during the 1st quarter worth about $1,954,941,000. GAMMA Investing LLC grew its holdings in Procter & Gamble by 20,758.5% during the 1st quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock worth $1,355,087,000 after acquiring an additional 7,913,335 shares in the last quarter. Capital Research Global Investors grew its holdings in Procter & Gamble by 62.5% during the 4th quarter. Capital Research Global Investors now owns 7,398,120 shares of the company's stock worth $1,240,294,000 after acquiring an additional 2,846,560 shares in the last quarter. Finally, Northern Trust Corp grew its holdings in Procter & Gamble by 10.1% during the 4th quarter. Northern Trust Corp now owns 29,395,208 shares of the company's stock worth $4,928,107,000 after acquiring an additional 2,703,757 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company's stock.

About Procter & Gamble

(Get Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Further Reading

Analyst Recommendations for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore
AI Stocks Are Printing Money — These 3 Are Just Getting Started

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines